Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 542 
IN FOCUS
Year : 2010  |  Volume : 16  |  Issue : 3  |  Page : 236-238

Use of budesonide in the treatment of microscopic colitis


Department of Medicine, The University of Western Ontario and London Health Sciences Centre, London, Ontario, Canada

Correspondence Address:
Vikram Tangri
C/O Dr. Nilesh Chande, Mailbox 55, London Health Sciences Centre, South St. Hospital, 375, South St., London, Ontario
Canada
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1319-3767.65188

Rights and Permissions

Collagenous colitis and lymphocytic colitis, the two types of microscopic colitis, cause watery diarrhea. Budesonide, a glucocorticoid medication with limited systemic availability, is commonly used to treat these illnesses. Budesonide has proven efficacy in the induction of clinical remission in both collagenous colitis and lymphocytic colitis. Budesonide is effective as a maintenance drug for patients with collagenous colitis, but has not been studied for this indication in patients with lymphocytic colitis. This drug improves quality of life in patients while causing few mild adverse events. Budesonide is an effective treatment of microscopic colitis that is safe and well tolerated.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5133    
    Printed221    
    Emailed4    
    PDF Downloaded629    
    Comments [Add]    
    Cited by others 2    

Recommend this journal